Abstract
The development of anticancer drugs from ethyl p-methoxycinnamate (EPMC) derivatives has been done to compounds high activity in inducing cancer cells apoptosis and minimal side effects. p-Methoxycinnamoyl hydrazide derivates, modified from EPMC structure, were docked into the ligand-binding pocket of Check point kinase 1 enzymes (2YWP) and the aromatase enzyme (3S7S) using software Molegro Virtual Docker (MVD) Ver.5.5. We compared the Rerank score of native ligand with p-Methoxycinnamoyl hydrazide derivates. Rerank scores of compounds 4b and 4c (-99.98 Kcal/mol and -99.80 Kcal/mol) were lower than the native ligand A42 in inhibiting the enzyme checkpoint kinase 1. Rerank values of p-Methoxycinnamoyl hydrazide derivate compounds were greater than the native ligand EXM in inhibiting the enzyme aromatase. p-Methoxycinnamoyl hydrazide derivate compounds, especially compounds 4b and 4c, had anticancer mechanism by inhibiting the checkpoint kinase 1 enzyme pathway and showed no activity in inhibiting the aromatase enzyme.
Bahasa Abstract
Pengembangan obat antikanker dari derivat Etil-p-metoksi Sinamat (EPMS) terus dilakukan untuk memperoleh senyawa yang memiliki level apoptosis sel kanker yang tinggi dengan efek samping yang minimal. Senyawa turunan p-Metoksisinnamoil hidrazida yang diperoleh dari modifikasi struktur dari EPMS ditambatkan dengan enzim Check Point Kinase 1 (2YWP) dan enzim Aromatase (3S7S) dengan menggunakan software Molegro Virtual Docker (MVD) Ver.5.5. Parameter penambatan yang digunakan yaitu nilai Rerank score native ligand dibandingkan dengan rerank score senyawa turunan p-Metoksisinnamoil hidrazida. Senyawa 4b dan 4c memiliki nilai rerank score -99,98 kkal/mol dan -99,80 kkal/mol yang lebih rendah dari native ligand A42 dalam menghambat enzim check point kinase 1. Senyawa turunan p-Metoksisinnamoil hidrazida memiliki nilai rerank score yang lebih besar dibandingkan native ligan EXM dalam menghambat enzim aromatase. Senyawa turunan p-Metoksisinnamoil hidrazida terutama senyawa 4b dan 4c memiliki mekanisme antikanker dengan jalur menghambat enzim check point kinase 1 dan tidak memiliki aktivitas dalam menghambat enzim aromatase.
References
Aroonkerk, N. & N. Kamkaen. (2009). Anti-inflammatory Activity of Quercus Infectoria, Glycyrrhiza Uralensis, Kaempferia Galanga and Coptis Chinensis, The main Components of Thai Herbal Remedies for Aphthous Ulcer. J. Health Res, 23 (1), 17-22
Basu, Gargi D., Winnie S., Dietrich A., Lee T., Christopher R., Barbara A., Pinku M. (2006). A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Research. 8,.1-11
ChemBioDraw Ultra 13.0. (2012). Cambrigesoft. PerkinElmer, Inc
ChemBio3D Ultra 13.0. (2012). Cambrigesoft. PerkinElmer, Inc
Clemente, Monica., Ana R., David S., Lucia D., Asuncion M., Francesco S., Dolores P., Juan C., Susana D., Laura P. (2013). Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer. The Veterinary Journal. 197, 427–432
Dai, Yujie., Qiang W., Xiuli Z., Shiru J., Heng Z., Dacheng F.,& Peng Yu. (2010). Molecular docking and QSAR study on steroidal compounds as aromatase inhibitors. European Journal of Medicinal Chemistry. xxx, 1-9
Donovan, D., J. Brown., T. Bishop., E. Levis. (2001). Comparison of three in vitro human ‘angiogenesis’ assay with capillaries formed in vivo. Angiogenesis. 4, 131-121
Ekowati, Juni., Bimo A., Shigeru S., Kimio H., Sukardiman, Siswandono, Tutuk B. (2012). Structure modification of ethyl p-methoxycinnamate and their bioassay as chemopreventive agent against mice’s fibrosarcoma. International Journal of Pharmacy and Pharmaceutical Sciences. 4, 528-532
Ekowati, Juni., Marcellino R., Shigeru S., Tutuk B., Sukardiman, Adam H., Edy M. (2010). Structure Modification of Ethyl p-methoxycinnamate Isolated from Kaempferia galanga Linn. and Citotoxicity Assay of The Products on WiDr Cells. Indonesian Journal of Cancer Chemoprevention. 1, 12-18
Ekowati, J., Hardjono, S., Hamid, I.S.(2015). Ethyl p-methoxycinnamate from Kaempferia galangal inhibits angiogenesis through tyrosine kinase. UNIVERSA MEDICINA. 34, 43-51
Fischer, M. & Hubbard, E.R. (2011).Crystal structure of sialic binding protein. ScienceDirect. 18 (10), 471-478
Ghosh, Debashis., Lo, J., Morton, D.., Valette, D., Xi, J., Griswold, J., Hubbell, S., Egbuta, C., Jiang, W., Davies, H. M. L. (2012). Novel aromatase inhibitors by structure-guided design. Journal of Medicinal Chemistry.55, 8464-8476
Gobil, M. Vikransinh., Satyam K., Ajit K., Divita G., C Gopimohan, Kamlesh K. Synthesis. (2010). Biological evaluation and molecular docking of ary hydrazines and hydrazides for anticancer activity. Indian Journal of Experimental Biology. 48, 265-268
Hamid, Iwan Sahrial., Dady S., Hermin R. (2013). Hambatan Ekspresi Vascular Endothelial Growth Factor oleh Ekstrak Daun Sambung Nyawa pada Endotel Membran Korioalantois. Jurnal Veteriner. 14, 85-90
Iniguez, M. A., Rodriguez. A., Volpert, O. V., Fresno, M., Redondo, J. M. (2003). Cyclooxygenase-2 : therapeutic target in angiogenesis. Trends Mol Med. 9, 73-78
Katzung, B.G.,. Masters, S.B., Trevor, A.J. (2009). Basic & Clinical Pharmacology, 11th Edition..New York: McGraw-Hill Companies. 671-700
Meuth, M. (2010). Chk1 suppressed cell death. Cell Division 5:21.
Molegro Virtual Docker (MVD) 5.(2011).Molegro ApS.
Pangaribowo, Dian Agung. (2014). Molecular docking, sintesis dan uji aktivitas sitotoksik senyawa 1-benzoil-1,3-dimetilurea. Cakra Kimia (Indonesian E-Journal of Applied Chemistry). 2 : 1-6
Putra, G. S., Yuniarta, T. A., Syahrani, A., Rudyanto, M. (2016). Synthesis, molecular docking study and brine shrimp lethality test of benzoxazine and aminomethyl derivatives from eugenol. International Journal of Pharma Research & Review. 5 (4), 1-11
Ruswanto, Taufik H. (2013). Desain dan pemodelan molekul turunan 1,3-dibenzoil tiourea sebagai inhibitor chk1 secara in silico. Jurnal Kesehatan Bakti Tunas Husada. 9, 14-21
Sawy, Eslam., Heba M., Khalied M., Eman S., Amira M., Adel H. (2015). Synthesis, anticancer activity and molecular docking study of novel 1, 3-diheterocycles indole derivatives. International Journal of Pharmacy and Pharmaceutical Sciences. 7, 379-385
Song D.Q., Du N.N., Wang Y.M., He W.Y., Jiang E.Z., Cheng S.X. (2009). Synthesis and activity evaluation of phenylurea derivatives as potent antitumor agents. Bioorg Med Chem; 17, 3873–3878,
Sulistyowaty, M. I., Nugroho, A. E., Putra, G. S., Ekowati, J., Budiati, T. (2016). Syntheses, molecular docking study and anticancer activity examination of p-methoxycinnamoyl hydrazides. International Journal of Pharmaceutical and Clinical Research. 8(6), 623-627
Suvannang,Naravut., Chanin N., Chartchalerm I., Virapong P. (2011). Molecular Docking of Aromatase Inhibitors. Molecules. 16, 3597-3617
Sweetman, Sean. (2009). Martindale the complete drug refference (36th ed.). London : Phamaceutical Press. 670-700.
Umar, Muhammad Ihtisham., Mohd Z., Amirin S., Amin M., Fouad S., Loiy E., Rabia A., Mohamed B. (2014). Ethyl-p-methoxycinnamate isolated from kaempferia galanga inhibits inflammation by suppressing interleukin-1, tumor necrosis factor-a, and angiogenesis by blocking endothelial functions. CLINICS. 69, 134-144
Xiao, L., Liu, C., Li, Y. (2009). Ultrasound Promoted of Bis(substituted pyrazol-4-ylcarbonyl)-Substituted Thioureas. Molecules 14, 1423-1428
Wakeling, A.E. (2000). Similarities and distinctions in the mode of action of different classes of antioestrogens. Endocrine-Related Cancer. 7, 17-28
Winer, Eric P., Clifford H., Harold J., Antonio C., Kathleen I., James N., Rowan T., Richard G, Stephan B, Julie G., Melody A., Eleftherios P., Lori J., Timothy J., Trevor J., John B., Cheryl P., Judy P., Susan B., Amy S., George P., Mark R. (2005). American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004. Journal of clinical oncology. 23, 619-629
Recommended Citation
Putra, Galih Satrio; Sulistyowatya, Melanny Ika; Ekowati, Juni; and Budiati, Tutuk
(2018)
"Pemodelan Molekul Turunan p-Metoksi sinnamoil Hidrazida Sebagai Inhibitor Checkpoint Kinase 1 dan Inhibitor Aromatase secara In silico,"
Pharmaceutical Sciences and Research: Vol. 4:
No.
2, Article 2.
DOI: 10.7454/psr.v4i2.3708
Available at:
https://scholarhub.ui.ac.id/psr/vol4/iss2/2
Included in
Natural Products Chemistry and Pharmacognosy Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Pharmaceutics and Drug Design Commons